Statin Therapy
HIV infection confers elevated risk for ASCVD, CV events
Top prevention news of 2019: Women’s heart health, omega-3 updates and more
Top endocrinology news reports 2019: anti-aging, alternate-day fasting, insulin patch
Alirocumab may reduce stroke risk without increasing odds of hemorrhage
High-intensity statins confer reduced clinical, cerebral events in AF, stroke
High-intensity statins may reduce adverse clinical and/or cerebral events in patients with acute ischemic stroke and atrial fibrillation, with particularly strong efficacy in patients who underwent revascularization and are younger than 75 years, according to findings published in the Journal of the American Heart Association.
FDA approves CV event risk reduction indication for icosapent ethyl
CV event risk lower in women vs. men after non-ST segment elevation ACS
EVAPORATE
More mixed findings on omega-3, statins do not harm memory — top stories in cardiology
The top stories in cardiology last week included results from the VITAL trial presented at the American Heart Association Scientific Sessions that showed vitamin D and omega-3 did not reduce rates of first heart failure hospitalization, but researchers found that omega-3 supplementation could prevent recurrent heart failure hospitalizations.